There is no human trial of the injectable TB-500 fragment for tendon, muscle, or systemic recovery
Its important to do it right to stay safe and effective
For research interpretation, the most useful angiogenesis data are those that connect multiple levels of evidence: endothelial cell behavior in vitro, VEGFR2 marker changes, functional tube formation, and tissue-level vascular outcomes in a selected preclinical model
I have used this before with great success
Athletes with Acute Tendon Ruptures: Competitive athletes facing 6 to 12 month recovery timelines from Achilles or patellar tendon ruptures express interest in BPC-157 due to its demonstrated timeline compression in animal rupture models
Physician supervision, baseline bloodwork, and structured cycling represent the minimum standard for responsible use